Literature DB >> 18445618

Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus.

Simon C Warby1, Crystal N Doty, Rona K Graham, Jeffrey B Carroll, Yu-Zhou Yang, Roshni R Singaraja, Christopher M Overall, Michael R Hayden.   

Abstract

Proteolysis of mutant huntingtin is crucial to the development of Huntington disease (HD). Specifically preventing proteolysis at the capase-6 (C6) consensus sequence at amino acid 586 of mutant huntingtin prevents the development of behavioural, motor and neuropathological features in a mouse model of HD. However, the mechanism underlying the selective toxicity of the 586 amino acid cleavage event is currently unknown. We have examined the subcellular localization of different caspase proteolytic fragments of huntingtin using neo-epitope antibodies. Our data suggest that the nucleus is the primary site of htt cleavage at amino acid 586. Endogenously cleaved 586 amino acid fragments are enriched in the nucleus of immortalized striatal cells and primary striatal neurons where they co-localize with active C6. Cell stress induced by staurosporine results in the nuclear translocation and activation of C6 and an increase in 586 amino acid fragments of huntingtin in the nucleus. In comparison, endogenous caspase-2/3-generated huntingtin 552 amino acid fragments localize to the perinuclear region. The different cellular itineraries of endogenously generated caspase products of huntingtin may provide an explanation for the selective toxicity of huntingtin fragments cleaved at amino acid 586.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445618     DOI: 10.1093/hmg/ddn139

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  49 in total

1.  Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.

Authors:  Andrew T N Tebbenkamp; Cameron Green; Guilian Xu; Eileen M Denovan-Wright; Aaron C Rising; Susan E Fromholt; Hilda H Brown; Debbie Swing; Ronald J Mandel; Lino Tessarollo; David R Borchelt
Journal:  Hum Mol Genet       Date:  2011-04-22       Impact factor: 6.150

2.  Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.

Authors:  Kevin B Dagbay; Nicolas Bolik-Coulon; Sergey N Savinov; Jeanne A Hardy
Journal:  J Biol Chem       Date:  2017-02-02       Impact factor: 5.157

Review 3.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

4.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.

Authors:  Leslie Michels Thompson; Charity T Aiken; Linda S Kaltenbach; Namita Agrawal; Katalin Illes; Ali Khoshnan; Marta Martinez-Vincente; Montserrat Arrasate; Jacqueline Gire O'Rourke; Hasan Khashwji; Tamas Lukacsovich; Ya-Zhen Zhu; Alice L Lau; Ashish Massey; Michael R Hayden; Scott O Zeitlin; Steven Finkbeiner; Kim N Green; Frank M LaFerla; Gillian Bates; Lan Huang; Paul H Patterson; Donald C Lo; Ana Maria Cuervo; J Lawrence Marsh; Joan S Steffan
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

5.  Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound.

Authors:  Dagmar E Ehrnhoefer; Niels H Skotte; Jeanette Reinshagen; Xiaofan Qiu; Björn Windshügel; Priyadarshini Jaishankar; Safia Ladha; Olga Petina; Mehdi Khankischpur; Yen T N Nguyen; Nicholas S Caron; Adelia Razeto; Matthias Meyer Zu Rheda; Yu Deng; Khuong T Huynh; Ilka Wittig; Philip Gribbon; Adam R Renslo; Detlef Geffken; Sheraz Gul; Michael R Hayden
Journal:  Cell Chem Biol       Date:  2019-07-25       Impact factor: 8.116

Review 6.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

7.  An optimized activity-based probe for the study of caspase-6 activation.

Authors:  Laura E Edgington; Bram J van Raam; Martijn Verdoes; Christoph Wierschem; Guy S Salvesen; Matthew Bogyo
Journal:  Chem Biol       Date:  2012-03-23

8.  Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.

Authors:  Christian Landles; Kirupa Sathasivam; Andreas Weiss; Ben Woodman; Hilary Moffitt; Steve Finkbeiner; Banghua Sun; Juliette Gafni; Lisa M Ellerby; Yvon Trottier; William G Richards; Alex Osmand; Paolo Paganetti; Gillian P Bates
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

9.  Effect of methylprednisolone on the activities of caspase-3, -6, -8 and -9 in rabbits with acute spinal cord injury.

Authors:  Hong-Sheng Lin; Zhi-Sheng Ji; Li-Heng Zheng; Guo-Qing Guo; Biao Chen; Hao Wu; Guo-Wei Zhang
Journal:  Exp Ther Med       Date:  2012-04-18       Impact factor: 2.447

10.  Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease.

Authors:  Jasmine Ramcharitar; Steffen Albrecht; Veronica M Afonso; Vikas Kaushal; David A Bennett; Andrea C Leblanc
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.